tiprankstipranks
Trending News
More News >
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market
Advertisement

InMed Pharmaceuticals (INM) Income Statement

Compare
375 Followers

InMed Pharmaceuticals Income Statement

Last quarter (Q3 2025), InMed Pharmaceuticals's total revenue was $1.80M, an increase of 12.91% from the same quarter last year. In Q3, InMed Pharmaceuticals's net income was $-3.02M. See InMed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.29M$ 5.48M$ 1.40M$ 0.00$ 0.00
Gross Profit
$ 1.51M$ 1.86M$ 699.85K$ -197.03K$ -183.09K
Operating Expenses
$ 12.63M$ 12.96M$ 18.46M$ 9.94M$ 8.87M
Depreciation and Amortization
$ 826.76K$ 789.55K$ 658.96K$ 197.03K$ 183.09K
EBITDA
$ -10.30M$ -10.31M$ -17.10M$ -9.80M-
Operating Income
$ -11.12M$ -11.10M$ -17.76M$ -9.92M-
Other Income/Expenses
$ 637.29K$ 588.54K$ -6.19M$ 2.12M$ 60.73K
Pretax Income
$ -10.49M$ -10.51M$ -23.95M$ -10.20M-
Net Income
$ -10.50M$ -10.53M$ -23.95M$ -10.20M$ -8.94M
Per Share Metrics
Basic EPS
$ -10.07$ -43.00$ -426.90$ -470.60$ -581.10
Diluted EPS
$ -10.07$ -43.10$ -427.00$ -470.60$ -581.10
Weighted Average Shares Outstanding
-----
Weighted Average Shares Outstanding (Diluted)
-----
Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis